4 Oral GLP-1R Obesity Drugs in Race for Approval, Novo Nordisk Leads: Report
New Delhi, 02 November 2024: Obesity is a global health crisis, affecting millions and increasing the risk of serious conditions such as diabetes, heart disease, and certain cancers. As the…
Share